(Q40312993)

English

Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation

scientific article published on 21 June 2006

Statements

Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation (English)
0 references
0 references
0 references
Tonmoy Sharma
Catherine Reed
Ingrid Aasen
21 June 2006
1-3
73-83

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit